---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-25-016794"
form_type: "8-K"
ticker: "ESPR"
cik: "0001434868"
company_name: "Esperion Therapeutics, Inc."
filed_at: "2025-04-04T23:59:59+00:00"
generated_at: "2026-05-23T20:48:52.452720+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Esperion CCO Eric Warren to depart effective April 18, 2025

## Summary
- Eric Warren stepping down as Chief Commercial Officer, effective April 18, 2025.
- Departure not the result of any disagreement with the Company on operations, policies, or practices.
- No successor or interim CCO announced in the filing.

## SEC filing metadata
- accession: 0001628280-25-016794
- form_type: 8-K
- ticker: ESPR
- cik: 0001434868
- company_name: Esperion Therapeutics, Inc.
- filed_at: 2025-04-04T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1434868/000162828025016794/0001628280-25-016794-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1434868/000162828025016794/espr-20250404.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-25-016794
- JSON: https://secwatch.observer/filing/0001628280-25-016794.json
- Plain text: https://secwatch.observer/filing/0001628280-25-016794.txt

## Key facts
- Executive change
  Eric Warren departed as Chief Commercial Officer at Esperion Therapeutics, Inc..
  - Action: stepping down
  - Role: Chief Commercial Officer
  source text: Eric Warren was stepping down from his position as Chief Commercial Officer of the Company, effective as of April 18, 2025.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1434868/000162828025016794/0001628280-25-016794-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.